⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FATE News
Fate Therapeutics, Inc.
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
prnewswire.com
ARDX
FATE
MNKD
VRTX
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
globenewswire.com
MNKD
VRTX
FATE
ARDX
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
IPS Cell-Derived Platelets Market to Rise at 9.6% CAGR Through 2025-2031: Industry and Companies Analysis Featuring Megakaryon, Xueji Shengwu, Renerval, Help, Cynata, Fate, and Century Therapeutics - ResearchAndMarkets.com
businesswire.com
FATE
Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs
globenewswire.com
FATE
Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
FATE
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
globenewswire.com
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy
globenewswire.com
FATE
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
globenewswire.com
FATE